Physician profile
Edward Mezerhane
NPI 1063654218
$537,328.91
in general payments reported to CMS, 2019-2025
24 companies · $148K in 2025
The $148K reported for 2025 was more than what 99% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $39K · 2021: $84K · 2022: $52K · 2023: $75K · 2024: $75K · 2025: $148K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $193K · Consulting Fee: $44K · Honoraria: $27K · Travel and Lodging: $20K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650 · Education: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $193,107.00 |
| Consulting Fee | $44,443.00 |
| Honoraria | $26,575.00 |
| Travel and Lodging | $19,970.81 |
| Food and Beverage | $11,732.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
| Education | $201.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $308,477.66 | 2019-2025 | |
| Harmony Biosciences LLC | $67,704.20 | 2020-2025 | Wakix |
| Lilly USA, LLC | $64,383.51 | 2025 | Zepbound, Mounjaro |
| Axsome Therapeutics, INC. | $31,378.83 | 2023-2025 | Sunosi, Auvelity |
| Avadel Cns Pharmaceuticals, LLC | $30,661.97 | 2023-2025 | Lumryz |
| Idorsia Pharmaceuticals US INC | $16,492.48 | 2022-2024 | Quviviq |
| Eisai INC. | $11,465.77 | 2020-2024 | |
| Eli Lilly and Company | $2,700.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,039.94 | 2025 | |
| Inspire Medical Systems, INC. | $666.39 | 2019-2025 | Inspire |
| Fisher & Paykel Healthcare INC | $578.29 | 2019-2025 | Fisher & Paykel Healthcare |
| Resmed Corp | $192.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $115.39 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $111.78 | 2019 | |
| Livanova USA, INC. | $103.68 | 2023 | Thn Sleep Therapy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $89.60 | 2020 | |
| Medtronic, INC. | $58.98 | 2021 | |
| Arbor Pharmaceuticals, INC. | $48.22 | 2021 | |
| Azurity Pharmaceuticals, INC. | $43.36 | 2024 | Horizant |
| Itamar Medical INC | $16.39 | 2025 | Watchpatone |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mezerhane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.